The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor interventionSusan K. Peirce, Donald L. Durden|Cancer Chemotherapy and Pharmacology|2010Cited by 38
PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven MedulloblastomaAlok R. Singh, Donald L. Durden|PLoS ONE|2016Cited by 31